PROJECT 005-GASTROINTESTINAL CANCER RESEARCH PROGRAM PROJECT SUMMARY/ABSTRACT Cancers of the gastrointestinal tract represent some of the most common and most deadly malignancies in the United States and around the world. Within the catchment area of the Vanderbilt-Ingram Cancer Center (VICC) population of 3.6 million people, GI tract malignancies account for 14% of all new cancers and 16% of cancer deaths. The Gastrointestinal Cancer Research Program (GI), led by co-Leaders, Jordan Berlin, MD and Daniel Beauchamp, MD, has been a translational/clinical program within VICC since VICC?s inception. GI remains highly successful as measured by growth of extramural funding, recruitment of talented GI cancer-focused investigators, scientific training of young investigators, career development, high productivity of scientific research publications, competing for cancer-focused research grants, development of new technology such as non-invasive imaging methods, and expanding opportunities for patients with GI malignancies to benefit from translational science through participation in innovative clinical trials. Drs. Berlin and Beauchamp integrate the program members? efforts within GI and VICC, thereby empowering members and the larger VICC community to answer critical questions and generate high impact discoveries regarding mechanisms of GI tract carcinogenesis and cancer progression that will translate into effective preventive strategies, better treatments and outcomes for these malignancies. GI membership investigates the breadth of GI malignancies with special initiatives in colorectal (CRC), gastroesophageal (GE) and pancreatic cancers. GI is strengthened by close relationships with the Jim Ayers Institute for Precancer Detection and Diagnosis (Dan Liebler, MD, Director), the Epithelial Biology Center (Robert Coffey, MD, Director) and Phase I Research (Jordan Berlin, MD, Director). There are 37 program members from 9 departments and two schools. There is $11.7M in NCI funding and $4.9M in other peer reviewed cancer-related support for the last budget year. The program members have 538 publications; 29% that are intra-programmatic and 41% that inter-programmatic. The members also have 216 collaborative publications with investigators at other institutions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
6P30CA068485-20
Application #
9248566
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2016-04-30
Budget End
2016-08-31
Support Year
20
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Cardin, Dana B; Thota, Ramya; Goff, Laura W et al. (2018) A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer. Am J Clin Oncol 41:772-776
Bloodworth, Melissa H; Rusznak, Mark; Pfister, Connor C et al. (2018) Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology. J Allergy Clin Immunol 142:683-687.e12
Saito-Diaz, Kenyi; Benchabane, Hassina; Tiwari, Ajit et al. (2018) APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev Cell 44:566-581.e8
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Hormuth 2nd, David A; Weis, Jared A; Barnes, Stephanie L et al. (2018) Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer. Int J Radiat Oncol Biol Phys 100:1270-1279
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Vierra, Nicholas C; Dickerson, Matthew T; Jordan, Kelli L et al. (2018) TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion. Mol Metab 9:84-97
Schlegel, Cameron; Weis, Victoria G; Knowles, Byron C et al. (2018) Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease. Dig Dis Sci 63:356-365
Piñeros, Marion; Frech, Silvina; Frazier, Lindsay et al. (2018) Advancing Reliable Data for Cancer Control in the Central America Four Region. J Glob Oncol :1-11

Showing the most recent 10 out of 2462 publications